Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
73%
Breast Cancer
60%
Glucuronosyltransferase
60%
Atezolizumab
44%
Survival
41%
Dodonaea
41%
Drug
39%
Overall Survival
37%
Enzyme
36%
microRNA
36%
Vancomycin
32%
Diterpenoid
28%
Uridine Diphosphate
26%
Colorectal Cancer
26%
Anti-Inflammatory Drug
24%
Toxicity
24%
Glycosyltransferase
21%
Pharmacogenomics
21%
Biosimilar Agent
21%
Cytochrome P450
21%
Plant
21%
Protein
20%
Acid
19%
Progression Free Survival
18%
CYP3A4
18%
Phosphotransferase Inhibitor
17%
Combination Therapy
16%
Medicinal Plant
16%
Lung Cancer
16%
Heart Failure
16%
Receptor
16%
Active Metabolite
16%
Inflammation
15%
Adverse Event
15%
Diseases
14%
Immunotherapy
13%
Cancer Risk
13%
Tamoxifen
12%
Prostate Cancer
12%
Liver Cell Carcinoma
12%
Irinotecan
12%
Non-Steroidal Anti-Inflammatory Drug
12%
Non Small Cell Lung Cancer
12%
Chemotherapy
12%
Androgen
11%
Proton Pump Inhibitor
11%
Lapatinib
11%
Protein Kinase Inhibitor
11%
Base
10%
Drug Interaction
10%
Medicine and Dentistry
Patient
82%
Therapeutic Procedure
64%
Survival
53%
Combination Therapy
53%
Inpatient
52%
Overall Survival
43%
Atezolizumab
36%
Malignant Neoplasm
34%
Association
32%
Breast Cancer
30%
Gene
29%
Neoplasm
28%
Meta-Analysis
27%
Toxicity
21%
Metastatic Colorectal Cancer
21%
Patient-Reported Outcome
21%
Progression Free Survival
20%
Analysis
20%
Randomized Controlled Trial
19%
Indigenous
19%
Metabolism
18%
Learning
16%
Heart Failure
16%
Incidence
16%
Lung Cancer
16%
Monoclonal Antibody Therapy
16%
Personalized Medicine
16%
Uridine Diphosphate
16%
Glycosyltransferase
16%
Immune Checkpoint Inhibitor
15%
Pain
14%
Pharmacist
14%
Obesity
14%
Accuracy
14%
Development
13%
Systematic Review
13%
Monoclonal Antibody
13%
Cells
13%
Female
12%
Enzyme
12%
CYP2C19
12%
Pharmacogenomics
12%
Clopidogrel
12%
Medicine
11%
C Reactive Protein
11%
Monitoring
11%
Drug
11%
Chemotherapeutic Agent
11%
Pooled Analysis
11%
Cancer Cell
11%
Biochemistry, Genetics and Molecular Biology
Nested Gene
100%
Glucuronosyltransferase
75%
Cancer Cell
63%
Metabolic Pathway
61%
Regulatory Mechanism
52%
Glycosyltransferase
51%
Protein
40%
Lysozyme
36%
Cytochrome P450
34%
MicroRNA
30%
Overall Survival
24%
Survival
23%
Association
20%
Clinical Trial
20%
Glucuronidation
20%
Isoform
19%
Comprehension
19%
Yeast
17%
Accuracy
17%
Development
16%
Promoter Region
16%
CYP3A4
14%
Excretion
14%
Absorption
14%
Kinase
14%
UGT2B7
14%
Estrogen Receptor
14%
Marsupial
13%
Mutation
13%
Small Molecule
13%
Untranslated Region
12%
Progression Free Survival
12%
Statin
12%
Taxonomy
12%
Macropus eugenii
11%
Uridine Diphosphate
11%
Atorvastatin
11%
Genetic Polymorphism
11%
Cofactors
10%
CYP3A
10%
Protein Kinase
10%
Peroxisome Proliferator-Activated Receptor
10%
Butyric Acid
10%
microRNA
10%
Messenger RNA
10%
Androgen Receptor
10%
UGT2B17
10%
Gene Expression
9%
Molecular Dynamics
9%
Beta Blocker
9%